glp-1 ed receptor agonist use may be associated with a modest increase in erectile dysfunction (ED) risk in men with type 2 diabetes, a target trial emulation suggested. affects nearly 50% of Medicare will start covering weight-loss
Description
However, there are important considerations that affect how you approach physical activity during this time
Girth (circumference) measurements were taken at the midpoint of the shaft in both flaccid and erect states, per the study authors
English, Spanish
Mounjaro is approved in the EU for both indications treating type 2 diabetes and, as of 2024, for weight loss in qualifying patients [1][17]
Food peptides, gut microbiota modulation, and antihypertensive effects
She is the host of the podcast
